Health insurers and pharmacy benefits managers argue that drug prices should be tied to the benefits the products bring to patients, but the pharma industry has been slow to buy into that model.
from Forbes Real Time https://www.forbes.com/sites/arleneweintraub/2017/09/29/big-pharma-doesnt-want-health-outcomes-to-sway-pricing-at-least-not-yet/
via IFTTT
No comments:
Post a Comment